Perspectives in Clinical Research

: 2012  |  Volume : 3  |  Issue : 2  |  Page : 47--49

Inept media trials of clinical trials

NV Ramamurthy 
 A-22 Triveni, Gilbert Hill Rd, Andheri (West), Mumbai - 400 058, India

Correspondence Address:
N V Ramamurthy
A-22 Triveni, Gilbert Hill Rd, Andheri (West), Mumbai - 400 058

The Indian media in general, with the exception of a few domain expert journalists, have failed to comprehend the complexities involved in the clinical trial process. In the run up to the deadline-based coverage of a story, a majority of them fall short in conveying the right perspective to readers, but nevertheless they have been successful in sensationalizing an event in this arena. Possibly by unintended misrepresentation, or mostly out of ignorance of the nuances involved in the clinical trials process, the media has done more harm than good, and got away with it. On the other side, the industry has been reluctant to engage with the media in a meaningful dialog for too long now. It bears not only the consequences of damage to its professional reputation following such reportage, but also the repercussions of unnecessary clampdowns by the regulators. Science journalism in India has yet to rise as a profession.

How to cite this article:
Ramamurthy N V. Inept media trials of clinical trials.Perspect Clin Res 2012;3:47-49

How to cite this URL:
Ramamurthy N V. Inept media trials of clinical trials. Perspect Clin Res [serial online] 2012 [cited 2021 Jul 27 ];3:47-49
Available from:;year=2012;volume=3;issue=2;spage=47;epage=49;aulast=Ramamurthy;type=0